ethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate

C37H40N4O9S — CID 139846131

IUPACethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate
SMILESCCOC(=O)CON=C1CC(C)(COc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)Oc2c(C)c(C)c(O)c(C)c21
InChIInChI=1S/C37H40N4O9S/c1-7-46-31(42)18-49-40-27-16-37(5,50-34-21(3)20(2)33(43)22(4)32(27)34)19-48-25-12-13-26-28(15-25)41(6)30(38-26)17-47-24-10-8-23(9-11-24)14-29-35(44)39-36(45)51-29/h8-13,15,29,43H,7,14,16-19H2,1-6H3,(H,39,44,45)
InChIKeyOYYBNZAXQXVYMV-UHFFFAOYSA-N
MW716.81 g/mol
LogP5.58
Rot. Bonds12

About ethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate

ethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate (PubChem CID 139846131) has the molecular formula C37H40N4O9S and a molecular weight of 716.81 g/mol. Its IUPAC name is ethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate.

Molecular Properties

Compound Nameethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate
PubChem CID139846131
Molecular FormulaC37H40N4O9S
Molecular Weight716.81 g/mol
Exact Mass716.25
IUPAC Nameethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate
SMILESCCOC(=O)CON=C1CC(C)(COc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)Oc2c(C)c(C)c(O)c(C)c21
InChIInChI=1S/C37H40N4O9S/c1-7-46-31(42)18-49-40-27-16-37(5,50-34-21(3)20(2)33(43)22(4)32(27)34)19-48-25-12-13-26-28(15-25)41(6)30(38-26)17-47-24-10-8-23(9-11-24)14-29-35(44)39-36(45)51-29/h8-13,15,29,43H,7,14,16-19H2,1-6H3,(H,39,44,45)
InChIKeyOYYBNZAXQXVYMV-UHFFFAOYSA-N
XLogP5.58
TPSA159.80 Ų
H-Bond Donors2
H-Bond Acceptors13
Rotatable Bonds12
Heavy Atoms51
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500716.81
LogP ≤ 55.58
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'thioester', 'substructure': 'N/A'}

Analyze ethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of ethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate?
The IUPAC name of ethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate (CID 139846131) is ethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate.
What is the SMILES notation for ethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate?
The canonical SMILES for ethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate is CCOC(=O)CON=C1CC(C)(COc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)Oc2c(C)c(C)c(O)c(C)c21.
What is the InChIKey of ethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate?
The InChIKey is OYYBNZAXQXVYMV-UHFFFAOYSA-N. The full InChI is InChI=1S/C37H40N4O9S/c1-7-46-31(42)18-49-40-27-16-37(5,50-34-21(3)20(2)33(43)22(4)32(27)34)19-48-25-12-13-26-28(15-25)41(6)30(38-26)17-47-24-10-8-23(9-11-24)14-29-35(44)39-36(45)51-29/h8-13,15,29,43H,7,14,16-19H2,1-6H3,(H,39,44,45).
What are the key properties of ethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate?
ethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate has a molecular weight of 716.81 g/mol, XLogP of 5.58, 12 rotatable bonds, 2 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for ethyl 2-[[2-[[2-[[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]methyl]-3-methylbenzimidazol-5-yl]oxymethyl]-6-hydroxy-2,5,7,8-tetramethyl-3H-chromen-4-ylidene]amino]oxyacetate is sourced from PubChem (CID 139846131), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).